Psoriasis Clinical Trials in New York

Showing 101-109 of 109 trials

Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris.

NCT00220025

This study offers narrowband UVB light therapy to patients with both light and dark skin types who have 10% of their body involved with psoriasis vulgaris.

Psoriasis Vulgaris

Mary Sullivan-Whalen70 participantsStarted Jun 1999

New York, New York, United States

COMPLETEDPHASE3< 1 mile

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00195676

The two objectives of this study were to evaluate long-term efficacy and safety of adalimumab treatment in participants who had moderate to severe chronic plaque psoriasis and to evaluate the effectiveness of adalimumab retreatment in participants who had therapeutic response to adalimumab and were then withdrawn from adalimumab treatment.

Psoriasis

Abbott1,469 participantsStarted May 2004

Birmingham, Alabama, United States • Buckner 13075 PI, Alabama, United States • Scottsdale, Arizona, United States +101 more locations

Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris.

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis Trials in Other Cities

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

Treatment of Psoriasis Using Acitretin in HIV-Positive Patients

A Study for Adults With Plaque Psoriasis

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice

Other Conditions in New York